FMR LLC 13D and 13G filings for Regeneron Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 8,188,770 7.600% |
-2,128,637 (-20.63%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 10,317,407 9.630% |
-779,577 (-7.03%) |
Filing |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 11,096,984 10.362% |
287,238 (+2.66%) |
Filing |
| 2022-10-11 09:03 am Purchase |
2022-10-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 10,809,746 10.084% |
746,781 (+7.42%) |
Filing |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 10,062,965 9.518% |
-1,418,606 (-12.36%) |
Filing |
| 2021-02-08 10:31 am Sale |
2021-02-05 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 11,481,571 10.949% |
-723,674 (-5.93%) |
Filing |
| 2020-06-10 10:13 am Purchase |
2020-06-09 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 12,205,245 12.140% |
8,979,418 (+278.36%) |
Filing |